The bacteriophage P2 ogr gene product is a positive regulator of transcription from P2 late promoters. The ogr gene was originally defined by compensatory mutations that overcame the block to P2 growth imposed by a host mutation, rpoA109, in the gene encoding the a subunit of RNA polymerase. DNA sequence analysis has confirmed that this mutation affects the C-terminal region of the a subunit, changing a leucine residue at position 290 to a histidine (rpoAL290H). We have employed a reporter plasmid system to screen other, previously described, rpoA mutants for effects on activation of a P2 late promoter and have identified a second allele, rpoA155, that blocks P2 late transcription. This mutation lies just upstream of rpoAL290H, changing the leucine residue at position 289 to a phenylalanine (rpoAL289F). The effect of the rpoAL289F mutation is not suppressed by the rpoAL29OH-compensatory P2 ogr mutation. P2 ogr mutants that overcome the block imposed by rpoAL289F were isolated and characterized. Our results are consistent with a direct interaction between Ogr and the a subunit of RNA polymerase and support a model in which transcription factor contact sites within the C terminus of a are discrete and tightly clustered.
Many eubacterial genes and operons are under positive control, and the structures and DNA-binding sites of a number of prokaryotic transcriptional activators have been well characterized (for a review, see reference 1). The precise mechanism by which these regulatory proteins catalyze the initiation of transcription remains largely obscure. The identification of lambda repressor (9, 24, 27, 28) and catabolite gene activator protein (CAP) (3, 15, 65) mutants that were defective as activators but retained DNA-binding ability suggested that these proteins function by interacting directly with RNA polymerase. A rapidly growing body of genetic evidence supports a functional interaction between the C-terminal region of the ax subunit(s) of DNA-dependent RNA polymerase and specific transcriptional activators.
The earliest indication that the a subunit plays a role in positive control was provided by Escherichia coli mutation rpoA109 (61) , which prevents lytic growth of phage P2 and satellite phage P4 by interfering with phage late-gene expression. This mutation results in a leucine-to-histidine change in the C-terminal region of the ax subunit (16) . Activation of a P2 late promoter by phage-encoded late transcriptional activator Ogr (P2) or 8 (P4) is severely depressed in strains carrying the rpoA109 mutation (23) . Compensatory mutations that overcame this block were shown to affect Ogr or 8 (26, 61) , suggesting direct communication between these proteins and the ao subunit of RNA polymerase. Recently obtained evidence from a number of other systems, based on the isolation of additional rpoA mutants that are affected in the activation of certain positively regulated operons, is consistent with this model (for reviews, see references 33, 34, and 52). Affected activators include CAP-cyclic AMP (14, 31, 32, 66) , OmpR (17, 46, 55, 58) , FNR (44) , AraC, MelR, and CysB (20) . The general pattern that has emerged from the characterization of these mutants is that they are altered in the C-terminal region of the a polypeptide and that each rpoA mutation appears to be fairly specific, affecting only one or a small group of positively regulated promoters. Those mutations that affect the responsiveness of RNA polymerase to each activator tend to be tightly clustered, suggesting that each transcriptional activator interacts with a discrete domain within the C-terminal region of the a subunit to stimulate transcription.
To further define a domain of the ao subunit involved in interaction with the activators of P2 late-gene expression, we have determined the precise location of the rpoA109 mutation. In addition, we have examined other chromosomal alleles of rpoA for their effects on transcription from a cloned P2 late promoter. Our analysis indicates that most of these rpoA mutations have little effect on P2 late-promoter activation. However, one mutation, rpoA155 (rpoA L289F; 44) , severely impairs P2 late-gene expression and prevents P2 lytic growth. We have isolated and characterized rpoAL289F-compensatory P2 ogr mutants. Our results support a model of direct interaction of Ogr with a discrete domain of the a subunit of RNA polymerase.
MATERUILS AND METHODS
Culture media. The culture medium used was LB (45) supplemented when appropriate with antibiotics (ampicillin, 100 [ug/ml; tetracycline, 15 pug/ml; kanamycin, 60 tug/ml; chloramphenicol, 25 [ug/ml). For growth of P2, LB was supplemented to 0.5 mM with CaCl2.
Strains and plasmids. The bacterial strains and plasmids used in this study are listed in Table 1 . P1 transductions were done with P1 cml cdr as described by Miller (47) . Mutant rpoA alleles were introduced into strain C-la by cotransduction with zhc::TnlO. Since the cotransduction frequency of this TnlO with rpoA is approximately 50%, the rpoA gene from several Escherichia coli C C-la  C2121  C4595  C4613  C4618  C4620  C4622  C4624  C4626  C4628  C4631   Salmonella typhimurium   TN2540   TN1379  TN3611  TN3612  TN3613  TN3614  TN3615  TN3555  TN3556  TN4235   TN4236  LB5010   MS1439 F-prototrophic F-rpoA109 rpsL F-rpsL C-la rpoA50 zhc-3::TnlO C-la rpoA52 zhc-3::TnlO C-la rpoA53 zhc-3::TnlO C-la rpoA85 zhc-3::TnlO C-la rpoA54 zhc-3::TnlO C-la rpoA+ zhc-3::TnlO C-la rpoA341 zhc::TnlO C-la rpoA+ zhc::TnlO niques for recombinant DNA methodology were employed (45) , and enzymes were used as recommended by the suppliers.
Plasmid pBB106 is identical to PL-ogr plasmid pGC57 (23) , except that it carries the rpoA109 compensatory ogr allele, which replaces Tyr-42 with Cys (ogrY42C). To construct this plasmid, a 640-bp BamHI-BglII fragment carrying the lambda PL promoter from pRC23 (13) was ligated with pNB177 (23), which had been cleaved with BamHI. The resulting plasmid, pBB100, was cleaved with BamHI and ligated with a 2.4-kb BglII fragment carrying the lambda cI(ts) gene from pRK248cIts (4) to yield pBB105. A 1-kb fragment carrying the ogrY42C gene was isolated from plasmid pCV1 (12) following digestion with EcoRI and EcoRV and ligated with pBB105, which had been cleaved with the same two enzymes.
Competent cells were prepared by the rubidium chloride technique described in technical manual TM001 (Promega Corp., Madison, Wis.). Plasmid DNA isolated from E. coli was passed through strain TN2540, which modifies DNA but is defective in restriction, prior to transformation of other Salmonella strains.
CAT enzyme assay. Lysates of cultures containing reporter gene plasmid pFCAT100 and a compatible plasmid encoding Ogr (pGC57 or pBB106) or 8 (pGVB1) were assayed for chloramphenicol acetyltransferase (CAT) by the spectrophotometric method of Shaw (56) as described previously (23) . Protein concentrations were determined by the method of Bradford (7) , with the Bio-Rad (Richmond, Calif.) protein assay kit. Cells were grown to an optical density at 600 nm of 0.5 at 30'C in LB supplemented with the appropriate antibiotics, shifted to 420C to derepress expression of plasmid-encoded Ogr or 8 from PL, and assayed after an additional 30 min of incubation. Cultures of strains carrying tac promoter plasmid pSL130 were grown at 370C and assayed 45 min after addition of 1 mM isopropyl-3-D-thiogalactopyranoside (IPTG). CAT activity was determined for at least two independent single colony isolates of each plasmid-containing strain.
PCR amplification and DNA sequence analysis. Primers used for the PCR and DNA sequencing (Table 2) were purchased from Oligos Etc., Inc., Wilsonville, Oreg. For sequence analysis, the entire rpoA gene was amplified by using primers DJA3 and DJA4, DJA5, or DJA6. Amplification was done with bacterial colonies as described by Joshi et al. (36) . Colonies were picked with an inoculating loop into 50 Al of H20 and vortexed vigorously. A 5-1.l aliquot was used as the DNA template, and 1 tug of each of the appropriate primers was used in an otherwise standard PCR with reagents and protocols supplied by the manufacturer (Perkin-Elmer Cetus, Norwalk, Conn.). Prior to sequencing, the amplified products were separated by agarose gel electrophoresis and purified by subjecting the appropriate gel slice to several freeze-thaw cycles, followed by phenol extraction and ethanol precipitation. Sequencing was done with reagents and protocols supplied with the ABI dye terminator kit, and reactions were analyzed on an ABI Automated Sequencer. Flanking primers DJA3 and DJA5 (Table 2 ) and internal primers APN2, APN3, APN4, APC2, APC3, and APC4 (29) were used to sequence the entire gene.
Isolation and characterization of rpoA155-compensatory P2 mutants. P2 mutants able to form plaques on lawns of S. typhimurium strains carrying the rpoAlSS(L289F) mutation were isolated in two ways. P2 virl modified to escape restriction by S. typhimupium was obtained either by plating a high-titer phage stock directly on TN4236 or by plating on rm+ strain LB5010. Phage purified from the plaques which appeared on these plates were able to plate on TN4236 with an efficiency of plating of 1. Aliquots containing 3 x 109 to 3 X 1010 phage from such a stock were plated on lawns of TN4235 and incubated overnight at 370C. Extremely tiny plaques appearing at a frequency of 4 X 10-9 to 1 x 10-10 were picked, and phage were purified by plating on TN4235. Alternatively, approximately 108 P2 virl phage (unadapted to S. typhimurium) were plated on lawns of r-m+ rpoAlSS mutant strain MS1439, a derivative of LB5010 obtained by P1 transduction from TN4235. Small plaques appearing at a frequency of 10-6 on MS1439 turned out to be P2 old mutants, and these phage were unable to grow on TN4235. These findings will be reported elsewhere. Larger plaques appearing at a frequency of approximately 10-8 contained phage able to grow on TN4235; these were purified by plating on MS1439.
The ogr gene from mutant phage stocks derived from each method was sequenced as follows: 1 Al of lysate (approximately 10ll phage per ml) was diluted into 100 pA of H20; 3 pl was then used as the template in an otherwise standard PCR. The ogr gene was amplified by using flanking primers LC2 and OGR3RK (Table 2) , and the amplified fragment was gel purified and subjected to DNA sequence analysis as described above, with primers OGR3RK and TX ( Table 2 ). The sequence of the ogr gene from each mutant was determined in its entirety on both strands from two independent PCRs. RESULTS Sequence of rpoA109. Fujiki et al. (16) isolated the altered a subunit from an rpoA109 mutant and identified a tryptic peptide containing a histidine in place of leucine. The composition of this tryptic peptide, compared with the amino acid sequence encoded by the rpoA gene, is consistent with a mutation affecting one of a pair of leucine codons at residues 289 and 290. The sequence of the rpoA1O9 gene was determined directly from PCR-amplified genomic DNA of strain C2121. A single T-to-A transversion at nucleotide 868 in the rpoA coding sequence (C1T-->CAT) was found. This mutation results in a substitution of histidine for leucine at amino acid residue 290 in the a polypeptide (rpoAL290H). (Table 3) . When Ogr was supplied by a plasmid encoding the compensatory ogrY42C mutant, a slight reduction in CAT activity was seen in an rpoA + strain, but 40% of this level of expression was retained in a strain with the rpoAL290H mutation ( Table 3) .
Effects of other chromosomal alleles of rpoA on expression from PF: a severe reduction is conferred by the rpoA55 (L289F) mutation. Mutations in rpoA that affect positive control have been isolated in both E. coli and S. typhimurium. The location of each of the rpoA mutations tested in this study is shown in Fig. 1 .
Each of the chromosomal rpoA mutations reported to affect positive control in E. coli K-12 was moved by transduction into prototrophic C strain E. coli C-la, and activation of cat expression from pFCAT100 by Ogr (pGC57) or 8 (pGVB1) was assayed ( (2, 59) . This raises the possibility that such genes, if present in the strains in which the rpoA mutations were tested, could mask an effect of the polymerase mutation on normal P2 late-gene expression.
Some of the E. coli rpoA mutations we examined had no effect on expression from the cloned P2 late promoter, as discussed below, while others had small effects similar in magnitude to those previously reported for other promoters.
None of the mutations conferred a defect severe enough to affect phage growth noticeably (data not shown).
The rpoA341 (phs; rpoAK271E) mutation confers on E. coli a pleiotropic growth defect and leads to impaired transcription from at least three unlinked sets of genes, meUB, cysA, and the ara regulon, each of which requires a regulon-specific transcriptional activator (20, 21, 50, 51) . The reported levels of expression of the genes affected by the rpoAK271E mutation are 7% of the wild-type level for meL4B and araBAD and 14% for cysA, as measured in lacZ fusions (20) . The rpoAK271E mutation did not cause a significant reduction in cat expression from P2 late promoter PF or from Ptac, in either an E. coli C strain (Table 3) or the original E. coli K-12 mutant (data not shown).
Several mutations that affect E. coli porin gene expression have been shown to result in amino acid substitutions in the C-terminal part of a (17, 58; Fig. 1 ). We examined mutants isolated on the basis of a decrease in transcription from the ompF promoter (dip; 17), as well as one that suppresses the defect conferred by a mutation in envZ (sez; 58). The reported effects of the dip mutations on transcription from the ompF promoter are fairly modest, ranging from about 40 to 66% of that seen in an rpoA' strain (58) . Similar modest effects on activation of PF by Ogr or 8 were seen for rpoA52 (P323S): i.e., 60 and 64%, respectively, of that seen in an rpoA+ strain ( Table 3 ). The adjacent rpoA54 mutation (P322S) did not impair Ogr-or 8-dependent transcription from PF. Activation of PF by 8 was also unaffected by rpoA53 (G3S) and rpoA50 (L28F and P240S), but modest effects on activation by Ogr were seen for both mutants. Ogr-dependent expression was reduced to 33% of the wild-type level by the rpoAG3S mutation, while a twofold increase in expression was seen for rpoA50 ( Table 3) . The sez mutation, rpoA85 (P323L), caused a slight reduction in expression from PF in the presence of Ogr or B. A similar modest reduction was reported for ompF expression in an envZ' background (58); as shown in Table 3 , the same results were obtained for expression from the tac promoter. This mutation thus appears to affect transcription in general rather than interfere with positive control.
Two additional rpoA mutations that were isolated on the basis of a decrease in transcription from the ompF promoter have been described more recently (55), rpoA203 (A272T) and rpoA207 (E215K). Neither of these mutations impairs Ogr-or 8-dependent expression from PF (12a). We also tested the two characterized temperature-sensitive alleles of rpoA (29, 35 ) to see whether they affected P2 late-promoter activation at the permissive temperature. Both mutations affect the N-terminal region of the a subunit and, as expected, did not impair P2 growth or show a significant reduction in late-promoter activation (data not shown).
Five rpoA mutations in S. typhimurium that affect the induction of pepT and other anaerobically regulated oxrA (fnr)-dependent genes have been described (44); these mutations also change amino acids in the C-terminal part of the a subunit (Fig. 1) . Plasmids pFCAT100 and either pGC57 (Ogr) or pGVB1 (8) were introduced into Salmonella strains carrying each of these rpoA mutations and tested for levels of expression (Table 3) . Since the rpoA genes from S. typhimurium and E. coli encode a subunits with the same amino acid sequence (44) , the same interaction(s) between Ogr or 8 and the Salmonella at subunit as seen with E. coli would be predicted. Not surprisingly, levels of CAT expression from the PF promoter in the rpoA + Salmonella strain were very similar to those observed in E. coli. The effects of most of the oxrB alleles on FNR-dependent activation of the pepT promoter are relatively modest. Two mutations, rpoA154 (W321Ter) and rpoA153 (R317H), reduced activity to about two-thirds of the wild-type levels (44) . A similar-magnitude reduction was seen in Ogr-or 8-mediated expression of PF (Table 3) . Two mutations affecting amino acid residue 311, rpoA151 (G311E) and rpoA8 (G311R), had a somewhat more severe effect on pepT expression, reducing it to 31 and 27%, respectively, of the levels seen in rpoA+ strains (44) . These mutations had relatively little effect on activation of PF by Ogr or 8 ( Table 3 ). All four of these rpoA mutations were reported to have little effect on the growth of S. typhimurium or on expression of the E. coli lac operon on an F' plasmid (44); consistent with this, we saw little effect on transcription from the cloned tac promoter. In contrast, the rpoA155 (L289F) allele conferred a modest reduction in expression from the tac promoter, while expres- sion from PF in the presence of either Ogr or 8 was reduced drastically ( Table 3 ). Levels of CAT activity in the presence of Ogr were too low to be measured, while 8-mediated activity was less than 10% of that obtained in the rpoA' strain. This mutation affects the amino acid residue immediately adjacent to that altered by the ipoAL290H mutation. This region thus appears to be critical for the interaction of the a polypeptide(s) with the P2-or P4-encoded positive regulatory proteins. As described above, the compensatory ogrY42C mutation restored expression from PF in a strain carrying the rpoA L290H mutation to 40% of that seen in an rpoA+ strain. In contrast, this ogr mutation was not able to restore even partial expression in a strain carrying the rpoAL289F mutation (Table  3 ). This suggests that the block to interaction with the Ogr protein imposed by mutation of each of these adjacent residues is distinct and that the ogrY42C mutation does not simply result in a more effective activator.
An ogr mutation overcomes the block imposed by the rpoA155 (L289F) mutation. The failure of ogrY42C to restore transcription in a strain carrying the rpoAL289F mutation prompted us to isolate rpoAL289F-compensatory P2 mutants. We initially attempted to transduce the rpoA155 allele from S. typhimurium into E. coli. Repeated attempts to transduce rpoA155 into E. coli by using a P1 lysate prepared on galE mutant strain TN4235 were unsuccessful, despite the fact that we could transduce the allele into rpoA+ strains of S. typhimurium. This may be due to the fact that despite identity at the amino acid level, the nucleotide sequences of the rpoA genes of the two species differ by 2.4%, interfering with homologous recombination. However, P1 and P2 are serologically related and share adsorption specificity, and P2 has also been reported to grow on galE mutants of S. typhimurium (48) . We therefore carried out analysis of the effects of the rpoAL289F mutation on P2 and subsequent isolation of compensatory mutants in S. typhimurium. P2 stocks that would plate efficiently on galE mutants of S. typhimurium were generated by picking plaques of phage that had escaped restriction and then passaging them through the same strain. Such phage grow equally well on restrictionproficient S. typhimurium TN4236 and on derivatives of E. coli C, which are naturally restriction deficient. We also plated unmodified P2 stocks on MS1439, an rpoAL289F derivative of restriction-defective S. typhimunium LB5010. The rpoAL289F mutation blocks the growth of P2 in both backgrounds (Table  4 and data not shown), consistent with the transcriptional defect observed in the CAT assays (Table 3 ). Spontaneous P2 mutants that overcome the block imposed by the rpoAL289F mutation were isolated by plating the Salmonella-modified P2 on restriction-proficient rpoAlSS mutant strain TN4235 and by plating a standard P2 lysate (grown in E. coli C) on nonrestricting rpoAL289F mutant derivative MS1439. The ogr genes of several independent mutants obtained from each selection contained the same C-to-T transition at position 38; this changes codon 13 from Ala to Val (ogrA13V).
Mutations ogrY42C and ogrA13V differ in the ability to overcome the effects of the rpoAL29OH and ipoAL289F mutations. Table 4 summarizes the burst sizes of P2 derivatives on E. coli and S. typhimurium strains carrying the rpoAL290H and rpoAL289F mutations, respectively. Neither of the ogr mutations impaired the growth of P2 in rpoA+ strains; P2 ogrY42C actually appeared to grow better than P2 ogr in rpoA+ S. typhimurium. The ogrY42C mutation restored growth in strains with the rpoAL290H mutation but not in strains with the rpoAL289F mutation, consistent with the CAT fusion plasmid data reported in Table 3 . In fact, the burst size data suggest that the rpoAL289F mutant is more restrictive for P2 ogrY42C than for P2 ogr'. The ogrA13V mutant, in contrast, overcomes the block imposed by either the rpoAL290H or the rpoAL289F mutation.
DISCUSSION
We have demonstrated that point mutations affecting two adjacent amino acid residues in the C terminus of the a subunit, rpoAL290H and rpoAL289F, block activation of P2 late-gene transcription by both P2 Ogr and P4 8. Point mutations in rpoA affecting activation by specific regulators are generally clustered into discrete and nonoverlapping regions (33, 34, 52 ; Fig. 1 ), and the two mutations that we describe here are consistent with this general pattern. Ogr and 8 thus fit the definition of class I transcription factors proposed by Ishihama (34) . Like other class I transcription factors, these phageencoded activators appear to exert their effects via an interaction involving a discrete site within the C-terminal region of a. The effect of the rpoAL290H mutation appears to be highly specific; resistance to P2 and P4 is the only apparent phenotype associated with this change. The rpoAL289F mutation confers a broader range of defects, including a modest reduction in FNR-dependent pepT expression, partial auxotrophy for cysteine and methionine, and inability to be lysogenized by phage P22 (44) . The pleiotropic nature of this mutation, the fact that it confers a modest defect, and its location in a region of the C terminus of a different from that of those mutations with the strongest effects on pepT expression led to the suggestion (52) that the rpoAL289F mutation may affect transcription indirectly rather than disrupt a specific interaction between FNR and RNA polymerase. In contrast, the effect of rpoAL289F on P2 late transcription, as measured by expression from the PF-CAT fusion plasmid (Table 3) or by phage burst size ( (6, 12, 26) that activate P2 late transcription from the same sites (10, 11) . Nevertheless, there are some major differences in structure and function between the two proteins. 8, a much larger protein, contains two tandem Ogr-like domains (26) . Activation of transcription by Ogr, but not that by 8, appears to require a replicating template (19, 40, 43, 60) . Of special interest, therefore, are mutations that appeared to have differential effects on activation of transcription by the two phage-encoded proteins. The rpoASO allele, which carries two mutations (P240S and L28F), increased transcription in the presence of Ogr, while the rpoAG3S mutation caused a modest decrease in Ogr-mediated expression from PF without affecting activation by 8. Although these are small effects, they suggest that we may find differences in the way these two proteins interact with RNA polymerase.
The rpoAP323S, rpoAR317H, and rpoAW321ter mutations caused modest differences in P2 late transcription without a concurrent reduction in expression from Ptac. These reductions were similar in magnitude to the effects that have been described for these rpoA mutations on other activators. All three mutations affect residues close to the C terminus of ax; this may indicate that conformational changes in this region can have small and relatively nonspecific effects on the ability of a to respond to a variety of activators.
There is considerable genetic evidence in support of direct protein-protein interactions between the C terminus of a and certain transcription factors (see references 33, 34, and 52 for reviews). In addition to the rpoA alleles examined in this study, point mutations have been isolated in plasmid-borne copies of rpoA that impair CAP-dependent transcription from lacP1 and affect amino acid residues between 261 and 270 (14, 66) . The properties of two C-terminal a deletion mutants (30) that have been characterized extensively in vitro are also consistent with involvement of this region in positive control. An RNA polymerase holoenzyme carrying these truncated a subunits recognized promoters such as lacUV5 trp, or rpJ, expression of which is independent of positive regulatory proteins, but failed to respond to transcription activation of the lacP1 promoter by cyclic AMP-CAP (32) . Subsequent studies demonstrated that mutant RNA polymerases containing these truncated ao subunits were impaired in activation by OmpR (31), A CII (25), Pseudomonas TrpI (25) , Ada (53) , and OxyR (62) . Stimulation of the A PL promoter by integration host factor was also abolished (22) . In the cases of CAP at lacP1 (38) and OxyR at katG (62) , loss of cooperative binding of the activator and RNA polymerase was associated with the truncated a subunits. These results provide strong evidence that the carboxyl-terminal region is involved in interaction with at least some transcriptional regulatory proteins.
Igarashi and Ishihama (32) have proposed that the discrete clusters of rpoA mutations affecting different activators identify amino acids involved in direct contact between each transcriptional effector and RNA polymerase. It is also possible, however, that the effects of these mutations are more indirect. They could alter the conformation of RNA polymerase in such a way that interaction with the regulatory protein is affected or block an allosteric transition within RNA polymerase in response to the activator. Furthermore, recent evidence indicates that the C-terminal third of ax can participate directly in promoter recognition, making specific contacts with an upstream sequence element in the rrnB P1 promoter that is also present in a number of other strong promoters (49) . Therefore (37) . This is consistent with the notion that the block to activation imposed by the rpoAL290H mutation is due to steric hindrance of the interaction with Ogr, which can be relieved if the residue at 42 is replaced by one with a small side chain. Ogr protein with the Y42C substitution is able to interact with wild-type polymerase as well, although there is an approximately twofold reduction in CAT activity. The rpoAL289F-compensatory P2 ogrA13V mutant is also able to activate transcription with wild-type RNA polymerase, suggesting that like rpoAL290H, the rpoAL289F mutation does not disrupt a specific protein-protein contact that is restored directly by the compensatory mutation in the activator. Despite the fact that the two rpoA mutations affect adjacent residues, the constraints imposed on the interaction with Ogr must be different, since the ogrY42C mutation can compensate for rpoAL290H but not rpoAL289F. The ogrA13V mutation results in a protein that appears to be able to function with both mutant and wild-type RNA polymerases; this compensatory mutation may simply result in a more effective activator. While the residues affected by the two rpoA-compensatory mutations are not near one another in the primary sequence, Ogr is believed to contain a CYs4-coordinated Zn2+ binding domain (39) involving Cys residues at positions 4, 7, 35, and 39. It is possible, therefore, that amino acid residues 13 and 42 are in close proximity in the Ogr polypeptide. The fact that mutations in either of these residues can compensate for the rpoAL290H mutation is consistent with this model.
The analysis reported here provides genetic evidence consistent with a direct interaction between the P2-and P4-encoded transcriptional activators and the ax subunit of RNA polymerase. We have characterized two point mutations in rpoA that appear to be severely impaired in interaction with Ogr, and one of the rpoA-compensatory ogr mutants exhibits some allele specificity. Isolation and analysis of additional mutants should allow us to define the specific contacts between Ogr and a that are required for activation of P2 late transcription.
